164 related articles for article (PubMed ID: 25976039)
1. Differential expression of TLR3 and TLR4 in keratocystic odontogenic tumor (KCOT): A comparative immunohistochemical study in primary, recurrent, and nevoid basal cell carcinoma syndrome (NBCCS)--associated lesions.
Leonardi R; Perrotta RE; Crimi S; Matthews JB; Barbato E; dos Santos JN; Rusu M; Bufo P; Bucci P; Pannone G
J Craniomaxillofac Surg; 2015 Jul; 43(6):733-7. PubMed ID: 25976039
[TBL] [Abstract][Full Text] [Related]
2. Beta-catenin and survivin expression in keratocystic odontogenic tumor (KCOT). A comparative immunohistochemical study in primary, recurrent and nevoid basal cell carcinoma syndrome (NBCCS)-associated lesions.
Leonardi R; Matthews JB; Loreto C; Musumeci G; Campisi G; Lo Muzio L; dos Santos JN; Pastorino L; Bufo P; Pannone G
Histol Histopathol; 2013 Sep; 28(9):1175-84. PubMed ID: 23572266
[TBL] [Abstract][Full Text] [Related]
3. Expression of podoplanin in nevoid basal cell carcinoma syndrome-associated keratocystic odontogenic tumours.
Friedrich RE; Scheuer HA; Zustin J
Anticancer Res; 2012 May; 32(5):2125-7. PubMed ID: 22593499
[TBL] [Abstract][Full Text] [Related]
4. Clinical manifestations and treatment for keratocystic odontogenic tumors associated with nevoid basal cell carcinoma syndrome: a study in 25 Japanese patients.
Shimada Y; Morita K; Kabasawa Y; Taguchi T; Omura K
J Oral Pathol Med; 2013 Mar; 42(3):275-80. PubMed ID: 22882291
[TBL] [Abstract][Full Text] [Related]
5. PTCH1 gene mutations in Keratocystic odontogenic tumors: a study of 43 Chinese patients and a systematic review.
Guo YY; Zhang JY; Li XF; Luo HY; Chen F; Li TJ
PLoS One; 2013; 8(10):e77305. PubMed ID: 24204797
[TBL] [Abstract][Full Text] [Related]
6. Fibroblasts regulate variable aggressiveness of syndromic keratocystic and non-syndromic odontogenic tumors.
Hong YY; Yu FY; Qu JF; Chen F; Li TJ
J Dent Res; 2014 Sep; 93(9):904-10. PubMed ID: 24972872
[TBL] [Abstract][Full Text] [Related]
7. Novel PTCH1 mutations in patients with keratocystic odontogenic tumors screened for nevoid basal cell carcinoma (NBCC) syndrome.
Pastorino L; Pollio A; Pellacani G; Guarneri C; Ghiorzo P; Longo C; Bruno W; Giusti F; Bassoli S; Bianchi-Scarrà G; Ruini C; Seidenari S; Tomasi A; Ponti G
PLoS One; 2012; 7(8):e43827. PubMed ID: 22952776
[TBL] [Abstract][Full Text] [Related]
8. Conservative Treatment of Multiple Keratocystic Odontogenic Tumors in a Young Patient with Nevoid Basal Cell Carcinoma Syndrome by Decompression: A 7-year Follow-up Study.
Kim SH; Oh MS; Seo YS; Kim JY; Nam SH; Lim SM
J Clin Pediatr Dent; 2017; 41(4):300-304. PubMed ID: 28650783
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the neoplastic nature and biological potential of sporadic and nevoid basal cell carcinoma syndrome-associated keratocystic odontogenic tumor.
Katase N; Nagatsuka H; Tsujigiwa H; Gunduz M; Tamamura R; Pwint HP; Rivera RS; Nakajima M; Naomoto Y; Nagai N
J Oral Pathol Med; 2007 Oct; 36(9):550-4. PubMed ID: 17850439
[TBL] [Abstract][Full Text] [Related]
10. PTCH1 and SMO gene alterations in keratocystic odontogenic tumors.
Sun LS; Li XF; Li TJ
J Dent Res; 2008 Jun; 87(6):575-9. PubMed ID: 18502968
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of matrix metalloproteinases (1, 2, and 9), Ki-67, and myofibroblasts in keratocystic odontogenic tumors and pericoronal follicles.
de Oliveira Ramos G; Costa A; Meurer MI; Vieira DS; Rivero ER
J Oral Pathol Med; 2014 Apr; 43(4):282-8. PubMed ID: 24822270
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of inactivation of PTCH1 gene in nevoid basal cell carcinoma syndrome: modification of the two-hit hypothesis.
Pan S; Dong Q; Sun LS; Li TJ
Clin Cancer Res; 2010 Jan; 16(2):442-50. PubMed ID: 20068110
[TBL] [Abstract][Full Text] [Related]
13. Keratocystic odontogenic tumor: a recurrence analysis of clinical and radiographic parameters.
Titinchi F; Nortje CJ
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Jul; 114(1):136-42. PubMed ID: 22727103
[TBL] [Abstract][Full Text] [Related]
14. Keratocystic odontogenic tumor associated with nevoid basal cell carcinoma syndrome: similar behavior to sporadic type?
Figueroa A; Correnti M; Avila M; Andea A; DeVilliers P; Rivera H
Otolaryngol Head Neck Surg; 2010 Feb; 142(2):179-83. PubMed ID: 20115971
[TBL] [Abstract][Full Text] [Related]
15. Significance of podoplanin expression in keratocystic odontogenic tumor.
Okamoto E; Kikuchi K; Miyazaki Y; González-Alva P; Oku Y; Tanaka A; Yoshida N; Fujinami M; Ide F; Sakashita H; Kusama K
J Oral Pathol Med; 2010 Jan; 39(1):110-4. PubMed ID: 19925582
[TBL] [Abstract][Full Text] [Related]
16. Multiple keratocystic odontogenic tumors associated with nevoid basal cell carcinoma syndrome having distinct PTCH1 mutations: a case report.
Sasaki R; Miyashita T; Matsumoto N; Fujii K; Saito K; Ando T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Aug; 110(2):e41-6. PubMed ID: 20659694
[TBL] [Abstract][Full Text] [Related]
17. Sporadic versus syndromic keratocysts-Can we predict treatment outcome? A review of 102 cysts.
Noy D; Rachmiel A; Zar K; Emodi O; Nagler RM
Oral Dis; 2017 Nov; 23(8):1058-1065. PubMed ID: 28449413
[TBL] [Abstract][Full Text] [Related]
18. Molecular pathogenesis of keratocystic odontogenic tumors developing in nevoid basal cell carcinoma syndrome.
Suzuki M; Nagao K; Hatsuse H; Sasaki R; Saito K; Fujii K; Miyashita T
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Sep; 116(3):348-53. PubMed ID: 23953420
[TBL] [Abstract][Full Text] [Related]
19. Non-syndromic and syndromic keratocystic odontogenic tumors: systematic review and meta-analysis of recurrences.
Antonoglou GN; Sándor GK; Koidou VP; Papageorgiou SN
J Craniomaxillofac Surg; 2014 Oct; 42(7):e364-71. PubMed ID: 24815763
[TBL] [Abstract][Full Text] [Related]
20. Underestimated PTCH1 mutation rate in sporadic keratocystic odontogenic tumors.
Qu J; Yu F; Hong Y; Guo Y; Sun L; Li X; Zhang J; Zhang H; Shi R; Chen F; Li T
Oral Oncol; 2015 Jan; 51(1):40-5. PubMed ID: 25458233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
